Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Drug Daily Bulletin > Results of Lymphoseek Phase III Clinical Trials in Melanoma Published in Annals of Surgical Oncology

FDAnews Drug Daily Bulletin

Oct. 11, 2012 | Vol. 9 No. 200

Results of Lymphoseek Phase III Clinical Trials in Melanoma Published in Annals of Surgical Oncology

Navidea Biopharmaceuticals announced the peer-reviewed publication of results from two Phase III clinical trials of Lymphoseek (technetium 99m tilmanocept) in patients with melanoma of the skin.
Daily Finance

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Pharma Blog Watch Clinic Becomes Pharma-Free Through Education, Staff Input GSK to Shut Down Tablet-Packaging Facility in Melbourne Global Recommendations on Child Medicine

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.